You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage 6 arteritis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

Not yet recruiting
  • Giant Cell Arteritis
  • +2 more
  • Optic nerve ultrasound
  • Joliette, Quebec, Canada
  • +3 more
Feb 18, 2023

Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

Recruiting
  • Rheumatoid Arthritis
  • +3 more
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Apr 25, 2022

    Takayasu Arteritis, Tocilizumab, Adalimumab Trial in Shanghai (Tocilizumab, Adalimumab)

    Recruiting
    • Takayasu Arteritis
    • +3 more
    • Tocilizumab
    • Adalimumab
    • Shanghai, Shanghai, China
      Department of Rheumatology in Zhongshan hospital, Fudan Universi
    Aug 7, 2021

    The Registry Study of Takayasu Arteritis in East China

    Recruiting
    • Takayasu Arteritis
    • +4 more
    • Shanghai, Shanghai, China
      Department of Rheumatology in Zhongshan hospital, Fudan Universi
    Aug 7, 2021

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 27, 2023

    End-stage Heart Failure Trial in Beijing (Corheart 6 Left Ventricular Assist System)

    Completed
    • End-stage Heart Failure
    • Corheart 6 Left Ventricular Assist System
    • Beijing, Beijing, China
      Fuwai Hospital, Chinese Academy of Medical Sciences
    Jun 28, 2023

    HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

    Completed
    • HER2-positive Breast Cancer
    • +8 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • (no location specified)
    May 22, 2023

    High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

    Recruiting
    • High-risk Stage II Colorectal Cancer
    • +2 more
    • mFOLFIRINOX adjuvant chemotherapy
    • mFOLFOX6/XELOX adjuvant chemotherapy
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 12, 2023

    Peripheral Neuropathy, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Columbus (Educational

    Completed
    • Peripheral Neuropathy
    • +6 more
    • Educational Intervention
    • +4 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Oct 10, 2022

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Houston, Texas
    • +4 more
    Oct 20, 2022

    Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7 Trial in

    Active, not recruiting
    • Stage II Breast Cancer AJCC v6 and v7
    • +6 more
    • Behavioral, Psychological or Informational Intervention
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 6, 2022

    Colorectal Cancer Trial (mFOLFOXIRI, mFOLFOX6)

    Not yet recruiting
    • Colorectal Cancer
    • (no location specified)
    Jun 17, 2022

    Stage 0 Breast Cancer AJCC v6 and v7, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in United States

    Recruiting
    • Stage 0 Breast Cancer AJCC v6 and v7
    • +10 more
    • Telemedicine
    • +6 more
    • Washington Township, New Jersey
    • +4 more
    Oct 18, 2022

    Tinnitus Trial in Dublin (PS1-PS4, PS6-PS10, PS7-PS4)

    Completed
    • Tinnitus
    • PS1-PS4
    • +3 more
    • Dublin, Ireland
      St. James's Wellness Trust Clinical Research Facility
    Sep 26, 2022

    Melanoma, Unresectable Melanoma Trial in Los Angeles, Boston, New York (Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab)

    Not yet recruiting
    • Melanoma
    • Unresectable Melanoma
    • Los Angeles, California
    • +3 more
    Aug 4, 2022

    Breast Cancer Trial (Abemaciclib, Letrozole)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Nov 14, 2023

    VCRC Tissue Repository

    Recruiting
    • Aortitis
    • +10 more
      • Boston, Massachusetts
      • +7 more
      Jan 25, 2022

      End Stage Kidney Disease Trial in Atlanta, Decatur (Continuous glucose monitoring (CGM))

      Recruiting
      • End Stage Kidney Disease
      • Continuous glucose monitoring (CGM)
      • Atlanta, Georgia
      • +3 more
      Feb 14, 2023

      Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

      Active, not recruiting
      • Metastatic Melanoma
      • +3 more
      • Jacksonville, Florida
        Mayo Clinic in Florida
      Jan 3, 2023

      Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

      Active, not recruiting
      • Metastatic Melanoma
      • +6 more
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Jan 13, 2023

      Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

      Active, not recruiting
      • Stage III Fallopian Tube Cancer AJCC v7
      • +14 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 24, 2022

      Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Detroit (Laboratory Biomarker

      Active, not recruiting
      • Invasive Breast Carcinoma
      • +6 more
      • Detroit, Michigan
        Wayne State University/Karmanos Cancer Institute
      Jun 17, 2022

      Colorectal Carcinoma Trial (mFOLFOX6, FOLFIRI, pembrolizumab)

      Active, not recruiting
      Has Results
      • Colorectal Carcinoma
      • (no location specified)
      Oct 28, 2022

      Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada

      Completed
      • Non-small Cell Lung Cancer
      • Calgary, Alberta, Canada
      • +4 more
      Jun 28, 2023